Definium Therapeutics Inc. Common Shares vs NiSource Inc Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while NiSource Inc Common Stock trades at $40.6 (market cap $19.44B). The key difference: NiSource Inc Common Stock is far larger — about 4.1× Definium Therapeutics Inc. Common Shares's market cap, and NiSource Inc Common Stock pays a 2.96% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and NiSource Inc Common Stock for 0 Days on average.
| DFTX | NI | |
|---|---|---|
Market Cap | $4.71B | $19.44B |
Volume | 1,966,636 | 4,902,101 |
Sector | Health | Utilities |
52-Week High | $48.45 | $49.08 |
52-Week Low | $10.68 | $39.00 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $36.77B |
Dividend Yield | — | 2.96% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →NiSource is an energy holding company whose regulated subsidiaries provide natural gas and electricity services. Its business is organized around gas distribution and electric operations in the United States.
Read more on NI →